VMI
ANAB icon

VHCP Management II’s AnaptysBio ANAB Stock Holding History

VHCP Management II’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-180,950
Closed -$18.8M – 19
2018
Q1 		$18.8M Sell
180,950
-101,600
-36% -$11.5M 4.54% 7
2017
Q4 		$28.5M Buy
282,550
+115,000
+69% +$8.47M 6.82% 6
2017
Q3 		$5.86M Buy
+167,550
New +$4.52M 1.62% 12

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VHCP Management II's ANAB Position: Q2 2018 in Review

VHCP Management II sold out of AnaptysBio (ANAB) in Q2 2018, closing a stake of 180,950 shares — an estimated $18.8M sold.

VHCP Management II first reported a position in ANAB in Q3 2017 and held it in 3 quarters. The position peaked at $28.5M in Q4 2017. 124 funds tracked by Wall St. Rank hold ANAB as of Q2 2018.

  • VHCP Management II reported no remaining AnaptysBio position as of Q2 2018 after selling out during the quarter.
  • VHCP Management II sold 180,950 AnaptysBio shares in Q2 2018, an estimated $18.8M.
  • VHCP Management II first reported a position in AnaptysBio in Q3 2017 and held it in 3 quarters.
  • VHCP Management II's AnaptysBio position peaked at $28.5M in Q4 2017.
  • 124 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2018.

Based on VHCP Management II's 13F filing for Q2 2018, filed 13 Aug 2018.